Remifentanil Attenuates Systemic Inflammatory Response in Patients undergoing Cardiac Surgery with Cardiopulmonary Bypass

Hyun Jung Lee,Tran Duc Tin,Sang Hyun Kwak,Sung Su Chung,Jin Young Kim

doi:10.21767/1989-5216.1000237

Hyun Jung Lee, Tran Duc Tin + Show 3 more

Open Access

https://doi.org/10.21767/1989-5216.1000237

Copy DOI

Journal: Archives of medicine	Publication Date: Jan 1, 2017
Citations: 3	License type: cc-by

Affiliation: Chonnam National University

Abstract

Background: Systemic inflammatory response plays pivotal roles in the pathogenesis of organ dysfunction after cardiac surgery with cardiopulmonary bypass (CPB). The aim of this study was to investigate whether remifentanil has the effects on the systemic inflammatory response induced by cardiac surgery with CPB. Methods: Sixty adult patients undergoing cardiac surgery with CPB were randomly assigned to two groups: a remifentanil (n=30) and a fentanyl group (n=30). The plasma levels of IL-6, IL-8 and malondialdehyde (MDA) were measured at preinduction (T1), just before aortic clamping (T2), just before aortic declamping (T3), 5 (T4), 30 (T5), and 60 (T6) min after aortic declamping. Hemodynamic variables serially recorded at that same times. Myocardial cell damage as assessed by plasma level of creatine kinase-MB (CK-MB) and troponin T were measured before and 24 hours after surgery. Results: The levels of IL-6, IL-8 and MDA significantly increased from just before aortic declamping in both groups. In the remifentanil group, all of those were significantly lower compared to the fentanyl group from just before aortic declamping (P<0.05). The level of CK-MB and troponin T significantly increased at 24 hours after surgery than preoperative baseline in both groups. In the remifentanil group, both were significantly lower than fentanyl group at 24 hours after surgery. Conclusion: Remifentanil attenuates systemic inflammatory response more effectively than fentanyl in cardiac surgery with CPB. The mechanism of its effects is likely to be through proinflammatory cytokines (including IL-6, IL-8) and oxidative stress mediator (MDA).

Highlights

The obligatory systemic inflammatory response to cardiac surgery with cardiopulmonary bypass (CPB) has been associated with significant perioperative and long-term morbidity and mortality
Cardiac surgery with CPB initiates a profound systemic inflammatory response, characterized by increased level of inflammatory mediators and oxidative stress mediators which have been shown to be correlated with the incidence of organ dysfunction and adverse clinical outcome [1]
The aim of our study was to investigate the effect of exogenous administration of opioids on the systemic inflammatory response induced by cardiac surgery with CPB

Summary

Introduction

The obligatory systemic inflammatory response to cardiac surgery with cardiopulmonary bypass (CPB) has been associated with significant perioperative and long-term morbidity and mortality. Cardiac surgery with CPB initiates a profound systemic inflammatory response, characterized by increased level of inflammatory mediators and oxidative stress mediators which have been shown to be correlated with the incidence of organ dysfunction and adverse clinical outcome [1]. No study has examined the direct role of opioids in the expression of pro-inflammatory mediators (including IL-6, and IL- 8) and malondialdehyde (MDA) in cardiac surgery with CPB. These observations provided the background for our hypothesis that exogenous opioids might attenuate the inflammatory response induced by cardiac surgery with CPB. The mechanism of its effects is likely to be through proinflammatory cytokines (including IL-6, IL-8) and oxidative stress mediator (MDA)

Objectives

Methods

Results

Conclusion